COCH Envoy Medical, Inc. logo

COCH Envoy Medical, Inc.

Healthcare
$0.71-3.26%ClosedMarket Cap: $14.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

4.63

P/S

63.02

EV/EBITDA

0.41

DCF Value

$0.03

FCF Yield

-140.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

-310.7%

Operating Margin

-9881.2%

Net Margin

-9875.6%

ROE

239.4%

ROA

-77.5%

ROIC

-130.0%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$39.0K$-4.4M$
Q4 null$75.0K$-6.6M$
FY null$241.0K$-23.8M$
Q3 null$42.0K$-6.5M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$6.00

Target (Median)

$6.00

Target Range

$6.00 - $6.00

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Ascendiant CapitalBuy
2025-05-27

Trading Activity

Insider Trades

View All
McKhann Chasdirector
SellFri Apr 17
McKhann Chasdirector:
SellFri Apr 17
Potashnick Robertofficer: Interim CFO
BuyTue Feb 17
Potashnick Robertofficer: Interim CFO
BuyTue Feb 17
Patel Mona Chetandirector
BuyTue Feb 17

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.90

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.

Peers